Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers
ClinicalTrials.gov ID NCT03388632
Sponsor National Cancer Institute (NCI)
Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party)
Interleukin-34 Level in Periodontal Disease
ClinicalTrials.gov ID NCT05962567
Sponsor Ain Shams University
Information provided by Nada Zidan, Ain Shams University (Responsible Party)
TNFalpha and Interleukin 2 Coding Oncolytic Adenovirus TILT-123 During TIL Treatment of Advanced Melanoma (TUNINTIL)
ClinicalTrials.gov ID NCT04217473
Sponsor TILT Biotherapeutics Ltd.
Information provided by TILT Biotherapeutics Ltd. (Responsible Party)